Registration for FDA’s Rare Disease Day 2024 (from Catapult’s regulatory round-up – December 2023)
The Virtual Public Meeting will be held on 1 March 2024 from 9AM – 4:30PM EST. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss:
- The legal framework for approving studies and medical products at FDA
- What FDA does during review processes to approve medical products
- Decentralized clinical trials and digital health technologies
- Where to find important information and documents related to clinical trials
- Information that can be obtained from medical product labels
- Legal and ethical requirements for consent forms in clinical trials
- FDA initiatives to advance medical product development for rare diseases
- Ways for patients to engage with FDA
Please find information on how to register here.
Published on the 5th of January 2024. Read the entire regulatory round-up for December 2023 here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (7 août 2024). Registration for FDA’s Rare Disease Day 2024 (from Catapult’s regulatory round-up – December 2023). ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/1258q





